Novacyt

Research Novacyt (ALNOV) on Bullrun: market cap EUR 27.97M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALNOV
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryMedical Devices
• CurrencyEUR
• Market capEUR 27.97M
• Financial periodFY2024
• RevenueEUR 19.63M
• Revenue growth84.8%
• Net income-EUR 41.76M
• Free cash flow-EUR 11.01M
• Gross margin163.4%

Valuation Snapshot

latest market cap is EUR 27.97M.

About Novacyt

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine.

Frequently asked questions

What is Novacyt's market cap?

Novacyt's market capitalization is EUR 27.97M.

What does Novacyt do?

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors. It operates through Yourgene Health and Primer Design segments.